The CMPK2–mtDNA axis mediates doxorubicin cardiotoxicity: mechanistic links to STAT1 transcription and FAD-mediated inhibition
CMPK2 is established as a key mediator of doxorubicin cardiotoxicity, integrating STAT1-mediated transcriptional regulation with mtDNA-dependent NLRP3 inflammasome activation into a unified pathological axis, addressing a major challenge in cardio-oncology.